October 23, 2014 4:45 PM ET

Pharmaceuticals

Company Overview of PreCision Dermatology, Inc.

Company Overview

PreCision Dermatology, Inc., along with its subsidiaries, develops, manufactures, and markets dermatology products. It offers pharmaceutical products for skin barrier restoration, dermatoses, rosacea, acne, seborrheic dermatitis, and scaling associated with hyperkeratotic skin. The company also provides therapeutic and cosmetic skincare solutions. It serves dermatology and skincare markets. PreCision Dermatology, Inc. was incorporated in 2010 and is based in Cumberland, Rhode Island. As of July 7, 2014, PreCision Dermatology, Inc. operates as a subsidiary of Valeant Pharmaceuticals International, Inc.

900 Highland Corporate Drive

Suite 203

Cumberland, RI 02864

United States

Founded in 2010

Phone:

401-762-2000

Fax:

401-762-2043

Key Executives for PreCision Dermatology, Inc.

Chief Executive Officer
Executive Chairman
Age: 71
Founder and Senior Advisor
Age: 67
Chief Financial Officer and Executive Vice President
Senior Vice President of Sales and Marketing-Onset Dermatologics
Age: 64
Compensation as of Fiscal Year 2014.

PreCision Dermatology, Inc. Key Developments

Glenmark Generics Inc. Files Lawsuit Against Astellas Pharma Europe B.V, Astellas International, Triax Pharmaceuticals, LLC, Precision Dermatology, Inc, Onset Dermatologics, LLC and Metacon Labs

Glenmark Generics Inc. has filed a lawsuit in the court of chancery of the state of Delaware against Astellas Pharma Europe B.V, Astellas International, Triax Pharmaceuticals, LLC, Precision Dermatology, Inc, Onset Dermatologics, LLC and Metacon Labs. The lawsuit seeks to enforce Glenmark's exclusive royalty-bearing license agreement with Triax Pharmaceuticals, Astellas Pharma Europe BV and Astellas Pharma International BV. Under that agreement, Glenmark is entitled to 180 days of exclusivity with respect to its Hydrocortisone Butyrate Cream, as it is the first generic company to file an abbreviated new drug application (ANDA) for the product.

Precision Dermatology Appoints Robert J. Moccia as Chief Executive Officer

Precision Dermatology Inc. announced that Robert J. Moccia has been appointed to the position of Chief Executive Officer. He most recently served as COO of Precision and President of Onset Dermatologics Inc.

Golub Capital Provides One-Loan Debt Facility to Support Refinancing of PreCision Dermatology, Inc

Golub Capital announced that as Sole Bookrunner and Administrative Agent it provided a $67 million GOLD financing to support the refinancing of PreCision Dermatology, Inc., backed by a syndicate of private equity sponsors including Essex Woodlands Health Ventures, Frazier Healthcare Ventures, Longitude Capital Partners, Boston Millennia Partners, Novaquest Capital Management, and Quaker Bioventures. GOLD financings are Golub Capital's One-Loan Debt facilities.

Similar Private Companies By Industry

Company Name Region
ProThera Biologics LLC United States
Sun Hope International Corporation United States
Sanofi US Services Inc. United States
Perardua Corp United States
Voyager Health Technologies Corp. United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
February 3, 2014
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PreCision Dermatology, Inc., please visit www.precisionderm.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.